NDC 17433-9886-05 - Enemeez Kids
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17433-9886
- Requested NDC
- 17433-9886-05
- Package NDCs from labels
- 17433-9886-0, 17433-9886-5, 17433-9886-6, 17433-9886-2, 17433-9886-05
- Manufacturer
- Quest Products LLC | Enemeez LLC DBA Summit Pharmaceuticals
- Effective date
- 2025-07-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Enemeez Kids - Quest Products LLC | Enemeez LLC DBA Summit Pharmaceuticals | Quest Products LLC | Enemeez LLC DBA Summit Pharmaceuticals | 2025-07-15 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17433-9886-0 | Enemeez Kids | 5 mL in 1 TUBE | LIQUID | 5 | 7 | |
| 17433-9886-2 | Enemeez Kids | 2 in 1 CONTAINER | LIQUID | 2 | 7 | |
| 17433-9886-5 | Enemeez Kids | 5 in 1 BOX | LIQUID | 5 | 7 | |
| 17433-9886-6 | Enemeez Kids | 6 in 1 CONTAINER | LIQUID | 6 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17433-9886 | ENEMEEZ KIDS (DOCUSATE SODIUM) LIQUID [QUEST PRODUCTS LLC] | 6 | Current NDC, Legacy NDC, 4 package rows | 20250216_f1602ba4-ad02-2936-e053-2995a90a27f2.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17433-9886-0 | ML - Milliliter | 17433-9886 | e42404ec-4e69-45eb-8a1b-b74f684a5d86 | 1 | 2025-10-14 |
| 17433-9886-2 | ML - Milliliter | 17433-9886 | 935644e3-beda-47d8-a19b-7c775eb64719 | 1 | 2025-09-12 |
| 17433-9886-5 | ML - Milliliter | 17433-9886 | 86e7a1e0-af8f-454f-a0a5-02e44a100632 | 1 | 2024-01-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Quality Choice Fiber Laxative | PSYLLIUM HUSK | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | 2ee637c4-c4c6-4a24-ae99-612205afd592 | 2026-10-29 | Warnings | M007 |
| Magnesium Citrate | EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - CHERRY | 4 Visions LLC | 5eeb0d66-06c7-7789-e063-6394a90aaff4 | 2026-10-28 | Warnings | M007 |
| Fiber Lax | CALCIUM POLYCARBOPHIL | PD-Rx Pharmaceuticals, Inc. | 730198a5-b6d9-4fc7-b053-a7c65a93c540 | 2026-10-27 | Warnings | M007 |
| Senna S | DOCUSATE SODIUM AND SENNOSIDES | Marlex Pharmaceuticals Inc | 9c87759f-3856-4f30-b5ea-4b37ed90f18c | 2026-10-27 | Warnings | M007 F05Q2T2JA0 |
| Sennosides | SENNOSIDES | Marlex Pharmaceuticals Inc | 5ca287a3-c4f6-402d-978e-cd1328bdbc47 | 2026-10-27 | Warnings | M007 |
| Sennosides | SENNOSIDES | PD-Rx Pharmaceuticals, Inc. | 829d24b7-a46a-4a29-88fe-180f35a2b6cd | 2026-10-27 | Warnings | M007 |
| QUALITY CHOICE Fiber Therapy | METHYLCELLULOSE | CHAIN DRUG MARKETING ASSOCIATION | 77ac079c-d957-4706-8241-570d7fcfe3aa | 2026-10-27 | Warnings | M007 |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 424d91f0-ecf9-6d9b-e063-6394a90a8006 | 2026-10-26 | Warnings | M007 PDC6A3C0OX |
| Family Wellness HEMORRHOID | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | FAMILY DOLLAR (Family Wellness) | 16ceb129-5c0a-428a-a867-cfbbb08bb62a | 2026-10-26 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 86c14327-ffc7-806e-e053-2991aa0aaf92 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Docusate Mini Enema | DOCUSATE SODIUM | Major Pharmaceuticals | 91099e15-94d7-b684-e053-2a95a90a574e | 2026-10-23 | Warnings | M007 F05Q2T2JA0 |
| CVS Mini Enema | DOCUSATE SODIUM W/BENZOCAINE | CVS HEALTH | ca00c520-410a-1905-e053-2995a90a56f0 | 2026-10-23 | Warnings | M007 F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | ATLANTIC BIOLOGICALS CORP. | c1f588d0-4600-4b97-b2d3-2c08ac351e07 | 2026-10-23 | Warnings | F05Q2T2JA0 |
| Clear Eyes Maximum Redness Relief | NAPHAZOLINE HYDROCHLORIDE AND GLYCERIN | Prestige Brands Holdings, Inc. | c3b0e344-68dd-4c35-bf46-744e612a5b15 | 2026-10-23 | Warnings | PDC6A3C0OX |
| LAXATIVE | BISACODYL | GRAXCELL PHARMACEUTICAL, LLC | 5a65d4ab-447f-42bb-b38d-070db523b806 | 2026-10-23 | Warnings | M007 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.